Kaplan Meyer plots of progression free survival (PFS) (A) and overall survival (OS) (B) in 35 metastatic melanoma patients treated with bevacizumab monotherapy.

<p>Early hypertension (EH) was significantly associated with PFS (C) and OS (D).</p>